Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics Jun 07 | 2026ADA 2026 Key Press Releases (June 6)Purchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other, Topics Jun 07 | 2026Reta Adcom % ＞ Zero?; Lilly ADA Investor EventPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Insulin Delivery, Other, Topics Jun 06 | 2026ADA 2026 Key Press Releases (June 5)Purchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics Jun 04 | 2026Dexcom Business Updates; PharmaSens All-in-One Patch Pump Feasibility Study; Fractyl REVEAL-1 Data; Daewoong H2H SGLT2i Trial; MHRA Approves RezdiffraPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other, Topics Jun 03 | 2026MiniMed FY Q1 ’26 Earnings; Insulet Enhances O5 Algorithm and Integrates with Libre 3 Plus CGM; myLoop AID and Dexcom G7 CGM Integration Launches in EUPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Insulin Delivery, Other, Topics Jun 02 | 2026Camurus and Lilly Expand Partnership; Merck Ph2 Oral PCSK9i + Lp(a) FDC; AZ Ph3 Laroprovstat + Rosuvastatin FDC Studies; MiniMed Flex Pre-Order Available; Ilant Series A FinancingPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other, Topics Jun 02 | 2026Obesity Spotlight Series: Pfizer Eyes Obesity Market Leadership with Questions Still UnansweredPurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Other, Topics Jun 01 | 2026Lilly Licenses GLP-2 from Hanmi; MannKind Pediatric Indication; Signos Raises $20M; Oura Ring GLP-1RA Feature; Apple Advances BG Monitoring?Purchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Glucose Monitoring, Other, Topics May 28 | 2026Dexcom G7 Sensor Recall; CVS to Cover Lilly AOMs; Tidepool on Epic Showroom; Galaxy Watch8 GLP-1RA Muscle Loss Study; France to Reimburse AOMsPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics May 27 | 2026Abbott Dual CGKM CE Mark; Kailera Q1 ’26 Earnings; MiniMed Go Smart MDI US Launch; Insulet Omnipod Medical Device CorrectionPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics May 27 | 2026ADA 2026 Preview: Where FENIX will be paying close attention and whyPurchase Blast
$599
Posted in: Basal Insulin, Other, Topics May 26 | 2026Lilly Interim Heart-2 Results; Ionis Q6M sHTG Study; CNPV Program Future; Biosimilar Lantus ApprovalPurchase Blast
$599
Posted in: GLP-1RA, Insulin Delivery, Other, Topics May 22 | 2026May CHMP Meeting Highlights; Lilly ATTAIN-1 and -2 Sub-analyses; Updated Beta Bionics Patch Pump Timeline; Novo Establishes UAE Distribution HubPurchase Blast
$599
Posted in: Dual/triple agonist, Other, Topics May 21 | 2026Lilly Delivers Best-in-class Weight Loss with New Reta Data; Bayer’s Kerendia Receives Priority ReviewPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other, Topics May 19 | 2026New Regeneron Obesity Asset; China-Based Oral GLP-1RA Touts Better Results than Orforglipron; Pfizer’s VESPER-6 PostedPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Glucose Monitoring, Other, Topics May 18 | 2026Another FDA Official Fired; AZ’s Baxdrostat Approved for HTN; Dexcom Flex to Launch in Germany; May CHMP AgendaPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other, Topics May 15 | 2026Generic Sema Now in Canada; Roche Posts Petrelintide + Enicepatide Study; Lilly Posts Ph2 Macupatide + Eloralintide Combo Study in ObesityPurchase Blast
$599
Posted in: Glucose Monitoring, Other, Topics May 15 | 2026Dexcom 2026 Investor Day; “Self-Adapting” G8 CGM to Launch Late-2027Purchase Blast
$599
Posted in: GLP-1RA, Other, Topics May 14 | 2026ProRx FDA Warning Letter; Lilly Partners with UNICEFPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Insulin Delivery, Other, Topics May 13 | 2026Makary Resigns; Novo OASIS 4 Data; Altimmune Q1 ’26 Earnings; Lilly SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN Full Data; Insulet Initiates O6 vs. O5 StudyPurchase Blast